- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Equine cIV antibody and antigen (recombinant protein)
Diagnostic anti-Equine cIV antibodies pairs and antigen for animal health (animal Equine/Horse Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
| Catalog No. | Description | US $ Price (per mg) |
|---|---|---|
| GMP-EQU-cIV-Ag01 | Equine cIV | $3090.00 |
| GMP-EQU-cIV-Ab01 | Anti-Equine cIV mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-cIV-Ab02 | Anti-Equine cIV mouse monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-cIV-Ab03 | Anti-Equine cIV human monoclonal antibody (mAb) | $3090.00 |
| GMP-EQU-cIV-Ab04 | Anti-Equine cIV human monoclonal antibody (mAb) | $3090.00 |
Size： 1mg | 10mg | 100mg
Product Description
| Cat No. | GMP-EQU-cIV-Ag01 |
| Product Name | Equine cIV |
| Target/Biomarker | Equine cIV |
| Expression platform | E.coli |
| Isotypes | Recombinant Antigen |
| Bioactivity validation | Anti-Equine cIV antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.. |
| Tag | His | Reconized/Reactive Specics | Equine cIV |
| Product description | Recombinant Equine cIV protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-cIV-Ab01,GMP-EQU-cIV-Ab02 |
| Target/Biomarker | Equine cIV |
| Product Name | Anti-Equine cIV mouse monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Mouse IgG |
| Bioactivity validation | Recombinant Equine cIV antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies in Equine cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.. |
| Product description | Anti-Equine cIV mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
| Cat No. | GMP-EQU-cIV-Ab03,GMP-EQU-cIV-Ab04 |
| Target/Biomarker | Equine cIV |
| Product Name | Anti-Equine cIV human monoclonal antibody (mAb) |
| Expression platform | CHO |
| Isotypes | Human lgG1 |
| Bioactivity validation | Recombinant Equine cIV antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine cIV antibodies in Equine cIV level test of animal Equine/Horse with Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.. |
| Product description | Anti-Equine cIV mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
| Formulation | Lyophilized from sterile PBS, PH 7.4 |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
Equine Collagen Type IV (cIV) emerges as a silent sentinel within the expansive tapestry of equine biology, a master of structural integrity that quietly fortifies the extracellular matrix. As a member of the collagen family, cIV boasts a triple helical structure composed of three distinct polypeptide chains—a configuration that marries strength with flexibility, ideal for its role as the cornerstone of basement membranes.
Basement membranes are far from passive foundations; they are bustling centers of cellular orchestration. cIV, at their core, offers not just architectural support but active participation in molecular signaling. Within basement membranes, cIV engages in intricate interplay with an ensemble of proteins and signaling molecules. This intricate web shapes a landscape where cellular adhesion, migration, growth, and differentiation are finely choreographed.
Imagine cIV as the conductor of a symphony, ensuring harmonious cellular interactions, safeguarding structural stability, and orchestrating a molecular ballet that regulates vital physiological processes. Its role extends beyond the mechanical; it bridges the physical and molecular worlds, an architect and a communicator.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Facebook
LinkedIn
Twitter
